A novel role for Oct-2 in the lipopolysaccharide-mediated induction of resistin gene expression in RAW264.7 cells

Biochemical Journal

Volumn 402, Issue 2, 2007, Pages 387-395

  Lu, Shao Chun ^a,d   Chang, Shwu Fen ^b   Chen, Hui Ling ^c   Chou, Yuan Yi ^a   Lan, Ya Hsin ^a   Chuang, Chia Ying ^a   Yu, Wei Hsuan ^a   Chen, Chia Lin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NONE   (Taiwan)

Author keywords

Lipopolysaccharide (LPS); Macrophage; Obesity; Oct 2; Octamer; Resistin

Indexed keywords

BIOASSAY; GENE EXPRESSION; LIPIDS; MACROPHAGES; PROTEINS; RNA;

IMMUNOPRECIPITATION ASSAYS; MOUSE RESISTIN PROMOTER; OBESITY; OCT-2; WESTERN BLOT;

POLYSACCHARIDES;

2 MORPHOLINO 8 PHENYLCHROMONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; RESISTIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; RETN PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; MACROPHAGE; MOUSE; MUTAGENESIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

MURINAE;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; CELL LINE; CHROMONES; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; MORPHOLINES; MUTAGENESIS; NITRIC OXIDE SYNTHASE TYPE II; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RESISTIN; RESPONSE ELEMENTS; RNA INTERFERENCE; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFECTION;

EID: 33847713258     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061096     Document Type: Article

References (42)

1. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S. and Lazar, M. A. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312
2. Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E., Watson, W., Kerr, K., Jones, R., Zhu, Q. and Considine, R. V. (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88, 5452-5455
3. Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A. and Saruta, T. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11, 997-1001
4. Rajala, M. W., Obici, S., Scherer, P. E. and Rossetti, L. (2003) Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest. 111, 225-230
5. Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E. et al. (2004) Regulation of fasted blood glucose by resistin. Science 303, 1195-1198
6. Rangwala, S. M., Rich, A. S., Rhoades, B., Shapiro, J. S., Obici, S., Rossetti, L. and Lazar, M. A. (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53, 1937-1941
7. Pravenec, M., Kazdova, L., Landa, V., Zidek, V., Mlejnek, P., Jansa, P., Wang, J., Qi, N. and Kurtz, T. W. (2003) Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278, 45209-45215
8. Satoh, H., Nguyen, M. T., Miles, P. D., Imamura, T., Usui, I. and Olefsky, J. M. (2004) Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114, 224-231
9. Way, J. M., Gorgun, C. Z., Tong, Q., Uysal, K. T., Brown, K. K., Harrington, W. W., Oliver, Jr, W. R., Willson, T. M., Kliewer, S. A. and Hotamisligil, G. S. (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists. J. Biol. Chem. 276, 25651-25653
10. Nagaev, I. and Smith, U. (2001) Insulin resistance and Type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285, 561-564
11. Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal-Puig, A., Considine, R. V. and O'Rahilly, S. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50, 2199-2202
12. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C. and Sharma, A. M. (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes. Res. 10, 1-5
13. Lee, J. H., Chan, J. L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C. and Mantzoros, C. S. (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88, 4848-4856
14. Holcomb, I. N., Kabakoff, R. C., Chan, B., Baker, T. W., Gurney, A., Henzel, W., Nelson, C., Lowman, H. B., Wright, B. D., Skelton, N. J. et al. (2002) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4055
15. Gomez-Ambrosi, J. and Fruhbeck, G. (2001) Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Ann. Intern. Med. 135, 306-307
16. Lu, S. C., Shieh, W. Y., Chen, C. Y., Hsu, S. C. and Chen, H. L. (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530, 158-162
17. Kaser, S., Kaser, A., Sandhofer, A., Ebenbichler, C. F., Tilg, H. and Patsch, J. R. (2003) Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309, 286-290
18. Harsch, I. A., Koebnick, C., Wallaschofski, H., Schahin, S. P., Hahn, E. G., Ficker, J. H., Lohmann, T. and Konturek, P. C. (2004) Resistin levels in patients with obstructive sleep apnoea syndrome: the link to subclinical inflammation? Med. Sci. Monit. 10, CR510-CR515
19. McTernan, P. G., Fisher, F. M., Valsamakis, G., Chetty, R., Harte, A., McTernan, C. L., Clark, P. M., Smith, S. A., Barnett, A. H. and Kumar, S. (2003) Resistin and Type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88, 6098-6106
20. Stejskal, D., Adamovska, S., Bartek, J., Jurakova, R. and Proskova, J. (2003) Resistin concentrations in persons with Type 2 diabetes mellitus and in individuals with acute inflammatory disease. Acta Univ. Palacki. Olomouc. Fac. Med. 147, 63-69
21. Lehrke, M., Reilly, M. P., Millington, S. C., Iqbal, N., Rader, D. J. and Lazar, M. A. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PloS Med. 1, 161-168
22. Tanaka, M. and Herr, W. (1990) Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60, 375-386
23. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159
24. -Delta;Delta;CT method. Methods 25, 402-408
25. Hartman, H. B., Hu, X., Tyler, K. X., Dalal, C. K. and Lazar, M. A. (2003) Mechanisms regulating adipocyte expression of resistin. J. Biol. Chem. 277, 19754-19761
26. Chou, S. F., Chen, H. L. and Lu, S. C. (2003) Sp1 and Sp3 are involved in up-regulation of human deoxyribonuclease II transcription during differentiation of HL-60 cells. Eur. J. Biochem. 270, 1855-1862
27. Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Zhang, M., McManus, M. T., Gertler, F. B., Scott, M. L. and Van Parijs, L. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406
28. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) Matlnd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884
29. Thommesen, L., Stunes, A. K., Monjo, M., Grosvik, K., Tamburstuen, M. V., Kjobli, E., Lyngstadaas, S. P., Reseland, J. E. and Syversen, U. (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J. Cell Biochem. 99, 824-834
30. Xie, Q. (1997) A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem. 272, 14867-14872
31. Tanaka, M., Lai, J. S. and Herr, W. (1992) Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68, 755-767
32. Dawson, S. J., Yoon, S. O., Chikaraishi, D. M., Lillycrop, K. A. and Latchman, D. S. (1994) The Oct-2 transcription factor represses tyrosine hydroxylase expression via a heptamer TAATGARAT-like motif in the gene promoter. Nucleic Acids Res. 22, 1023-1028
33. Staudt, L. M., Clerc, R. G., Singh, H., LeBowitz, J. H., Sharp, P. A. and Baltimore, D. (1988) Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory Octamer DNA motif. Science 241, 577-580
34. He, X., Treacy, M. N., Simmons, D. M., Ingraham, H. A., Swanson, L. W. and Rosenfeld, M. G. (1989) Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35-41
35. Kang, S. M., Tsang, W., Doll, S., Scherle, P., Ko, H. S., Tran, A. C., Lenardo, M. J. and Staudt, L.M. (1992) Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Mol. Cell. Biol. 12, 3149-3154
36. Lopez-Rodriguez, C., Zubiaur, M., Sancho, J., Concha, A. and Corbi, A. L. (1997) An Octamer element functions as a regulatory element in the differentiation-responsive CD11c integrin gene promoter: Oct-2 inducibility during myelomonocytic differentiation. J. Immunol. 158, 5833-5840
37. Clerc, R. G., Corcoran, L. M., LeBowitz, J. H., Baltimore, D. and Sharp, P. A. (1988) The B-cell-specific Oct-2 protein contains POU box- and homeobox-type domains. Genes Dev. 2, 1570-1581
38. Schreiber, E., Matthias, P., Müller, M. M. and Schaffner, W. (1988) Identification of a novel lymphoid specific Octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J. 7, 4221-4229
39. Miller, C. L., Feldhaus, A. L., Rooney, J. W., Rhodes, L. D., Sibley, C. H. and Singh, H. (1991) Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol. Cell. Biol. 11, 4885-4894
40. Wirth, T., Priess, A., Annweiler, A., Zwilling, S. and Oeler, B. (1991) Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res. 19, 43-51
41. Raabe, T., Bukrinsky, M. and Currie, R. A. (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide. J. Biol. Chem. 273, 974-980
42. Monick, M. M., Carter, A. B., Robeff, P. K., Flaherty, D. M., Peterson, M. W. and Hunninghake, G. W. (2001) Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J. Immunol. 166, 4713-20